| Authors: |
Held C; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden claes.held@ucr.uu.se.; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden., White HD; Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand., Stewart RAH; Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand., Budaj A; Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland., Cannon CP; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA., Hochman JS; Department of Medicine, NYU Langone Medical Center, New York, NY., Koenig W; Department of Internal Medicine II-Cardiology, University of Ulm Medical Center, Ulm, Germany.; Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany., Siegbahn A; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.; Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden., Steg PG; Département Hospitalo-Universitaire FIRE, AP-HP, Hôpital Bichat, Paris, France.; Paris Diderot University Sorbonne Paris Cité, Paris, France.; NHLI Imperial College, ICMS, Royal Brompton Hospital, London, United Kingdom.; FACT (French Alliance for Cardiovascular Trials), an F-CRIN network, INSERM U1148, Paris, France., Soffer J; Metabolic Pathways and Cardiovascular Therapeutic Area, GlaxoSmithKline, Collegeville, PA., Weaver WD; Henry Ford Heart and Vascular Institute, Detroit, MI., Östlund O; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden., Wallentin L; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden. |
